Longeveron Inc. (LGVN)
$6.72-$0.08 (-1.18%) Today
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 14 | 2,696,000 | |
| Tax withholding / forfeiture | 5 | 92,007 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
61 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nirav S. Jhaveri - Officer | Grant or award | Class A Common Stock | 300,000 | $0.00 | - | |
| Paul T. Lehr - Officer | Grant or award | Class A Common Stock | 286,000 | $0.00 | - | |
| Roger Joseph Hajjar - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Rock Soffer - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| George A. Paletta Jr. - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Ursula Ungaro - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Leah Rush Cann - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Arjun Jj Desai - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Devin Blass - Officer | Grant or award | Class A Common Stock | 286,000 | $0.00 | - | |
| Deborah Ascheim - Director | Grant or award | Class A Common Stock | 36,000 | $0.00 | - | |
| Nataliya Agafonova - Officer | Grant or award | Class A Common Stock | 286,000 | $0.00 | - | |
 Joshua Hare - Officer | Grant or award | Class A Common Stock | 286,000 | $0.00 | - | |
| Joshua Hare - Officer | Grant or award | Class B Common Stock | 600,000 | $0.00 | - | |
| Joshua Hare - Officer | Grant or award | Stock Option (right to buy) | 400,000 | $0.00 | - | |
| Stephen H. Willard - Officer | Tax withholding / forfeiture | Class A Common Stock | 18,046 | $7.29 | $13K | |
 Lisa Locklear - Officer | Tax withholding / forfeiture | Class A Common Stock | 22,505 | $7.29 | $16K | |
| Nataliya Agafonova - Officer | Tax withholding / forfeiture | Class A Common Stock | 22,505 | $7.29 | $16K | |
| Devin Blass - Officer | Tax withholding / forfeiture | Class A Common Stock | 15,808 | $7.29 | $12K | |
| Paul T. Lehr - Officer | Tax withholding / forfeiture | Class A Common Stock | 13,143 | $7.29 | $10K | |
| Paul T. Lehr - Officer | Grant or award | Class A Common Stock | 250,000 | $0.00 | - | |
| Stephen H. Willard - Officer | Grant or award | Class A Common Stock | 500,000 | $0.00 | - | |
| Devin Blass - Officer | Grant or award | Class A Common Stock | 250,000 | $0.00 | - | |
| Nataliya Agafonova - Officer | Grant or award | Class A Common Stock | 250,000 | $0.00 | - | |
| Lisa Locklear - Officer | Grant or award | Class A Common Stock | 250,000 | $0.00 | - | |
| Paul T. Lehr - Officer | Tax withholding / forfeiture | Class A Common Stock | 5,611 | $11.20 | $6K | |
| Nataliya Agafonova - Officer | Tax withholding / forfeiture | Class A Common Stock | 13,145 | $11.20 | $15K | |
| Lisa Locklear - Officer | Tax withholding / forfeiture | Class A Common Stock | 13,145 | $11.20 | $15K | |
| Stephen H. Willard - Officer | Tax withholding / forfeiture | Class A Common Stock | 4,740 | $11.20 | $5K | |
| Devin Blass - Officer | Tax withholding / forfeiture | Class A Common Stock | 8,633 | $11.20 | $10K | |
| Stephen H. Willard - Officer | Grant or award | Class A Common Stock | 200,000 | $0.00 | - | |
| Stephen H. Willard - Officer | Grant or award | Class A Common Stock | 200,000 | $0.00 | - | |
| Stephen H. Willard - Officer | Tax withholding / forfeiture | Class A Common Stock | 105,533 | $5.45 | $58K | |
| Stephen H. Willard - Officer | Grant or award | Stock Option (right to buy) | 200,000 | $0.00 | - | |
| George A. Paletta Jr. | Grant or award | Class A Common Stock | 34,000 | $0.00 | - |
Longeveron Inc. (LGVN) had 18 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for LGVN runs to 61 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of LGVN were filed in the last 90 days. 4 purchases are on record for this company.
No insider sales of LGVN were filed in the last 90 days. 1 sale is on record for this company.
This page tracks LGVN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add LGVN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
